Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Horm Behav ; 61(4): 642-51, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22570859

RESUMEN

Progesterone (PROG) has been shown to protect the brain from traumatic injury and is now in Phase III clinical trials. Our work shows that PROG's beneficial effects can be reduced in vitamin D hormone (VDH)-deficient subjects. VDH can modulate neuronal apoptosis, trophic factors, inflammation, oxidative stress, excitotoxicity, and myelin and axon repair. We investigated whether VDH combined with PROG could improve behavioral outcomes more than PROG alone in VDH-sufficient rats given bilateral contusions of the medial frontal cortex. PROG and different doses of VDH (1 µg/kg, VDH1; 2.5 µg/kg, VDH2; 5 µg/kg, VDH3) were injected intraperitoneally 1 h post-injury. Eight additional doses of PROG were given subcutaneously over 8 days with tapering over the last 2 days. Neurobehavioral tests, necrotic cavity, neuronal death and activation of astrocytes were evaluated 21 days post-injury. We found that PROG and PROG + VDH preserve spatial memory processing. VDH1 + PROG improved performance in acquisition more effectively than PROG alone, indicating that the low VDH dose is optimal for combination therapy. There were no significant differences in necrotic cavity size among the groups. The density of positive staining for reactive astrocytes (glial fibrillary acidic protein (GFAP)) increased and the cell bodies and processes of GFAP-positive cells were enlarged in the PROG + VDH1 group. Our data indicate that the combination of PROG and VDH is more effective than PROG alone in preserving spatial and reference memory, and that PROG plus low-dose VDH can activateGFAP reactions up to 21 days after injury. This effect may be one of the mechanisms underlying PROG's neuroprotective effects in combination with VDH.


Asunto(s)
Lesiones Encefálicas/complicaciones , Trastornos de la Memoria/etiología , Trastornos de la Memoria/prevención & control , Fármacos Neuroprotectores , Progesterona/farmacología , Vitamina D/farmacología , Vitaminas/farmacología , Animales , Astrocitos/efectos de los fármacos , Astrocitos/patología , Conducta Animal/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Lesiones Encefálicas/psicología , Muerte Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Fluoresceínas , Colorantes Fluorescentes , Lóbulo Frontal/lesiones , Lóbulo Frontal/patología , Proteína Ácida Fibrilar de la Glía/metabolismo , Inmunohistoquímica , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/psicología , Actividad Motora/efectos de los fármacos , Necrosis , Neuronas/efectos de los fármacos , Neuronas/patología , Progesterona/administración & dosificación , Desempeño Psicomotor/efectos de los fármacos , Desempeño Psicomotor/fisiología , Ratas , Ratas Sprague-Dawley , Trastornos de la Sensación/etiología , Trastornos de la Sensación/prevención & control , Sobrevida , Vitamina D/administración & dosificación , Vitaminas/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA